Last reviewed · How we verify
Imovax Rabies vaccine
Imovax Rabies vaccine is a Biologic drug developed by U.S. Army Medical Research and Development Command. It is currently in Phase 1 development.
At a glance
| Generic name | Imovax Rabies vaccine |
|---|---|
| Sponsor | U.S. Army Medical Research and Development Command |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M (PHASE2)
- Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming. (PHASE3)
- A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody (PHASE2)
- R21/Matrix-M in African Children Against Clinical Malaria (PHASE3)
- Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine (PHASE3)
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults (PHASE3)
- Washington University WU 409: Immune Responses to Rabies Vaccine. (EARLY_PHASE1)
- Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Imovax Rabies vaccine CI brief — competitive landscape report
- Imovax Rabies vaccine updates RSS · CI watch RSS
- U.S. Army Medical Research and Development Command portfolio CI
Frequently asked questions about Imovax Rabies vaccine
What is Imovax Rabies vaccine?
Imovax Rabies vaccine is a Biologic drug developed by U.S. Army Medical Research and Development Command.
Who makes Imovax Rabies vaccine?
Imovax Rabies vaccine is developed by U.S. Army Medical Research and Development Command (see full U.S. Army Medical Research and Development Command pipeline at /company/u-s-army-medical-research-and-development-command).
What development phase is Imovax Rabies vaccine in?
Imovax Rabies vaccine is in Phase 1.